Skip to main content
Veterinary Medicines

Temprace 0.5 mg/ml Solution for Injection for Dogs and Cats

Authorised
  • Acepromazine

Product identification

Medicine name:
Temprace 0.5 mg/ml Solution for Injection for Dogs and Cats
TEMPRACE 0,5 MG/ML SOLUTION INJECTABLE POUR CHIENS ET CHATS
Active substance:
  • Acepromazine
Target species:
  • Dog
  • Cat
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Acepromazine
    0.50
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05AA04
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • Clear type I glass vial of 10 ml closed with a coated bromobutyl rubber stopper and aluminium cap in a carton box
  • Clear type I glass vial of 20 ml closed with a coated bromobutyl rubber stopper and aluminium cap in a carton box
  • Clear type I glass vial of 100 ml closed with a coated bromobutyl rubber stopper and aluminium cap in a carton box

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/0144421 0/2017
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0321/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 25/01/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."